The Weave Bio NDA Workflow extends the platform’s capabilities to support New Drug Application submissions. Developed in partnership with Parexel, this expansion reflects how teams are applying AI across the full regulatory lifecycle.
Preparing an NDA requires bringing together years of clinical, non-clinical, and manufacturing data under tight timelines and high expectations. Historically, this has meant months of manual work. With the introduction of NDA workflows, Weave continues building a human-driven, AI-enabled platform designed to support teams through these critical moments.
The launch of NDA support reflects a broader shift in how regulatory teams approach document development. As programs grow in complexity, teams need systems that connect data, decisions, and content across the lifecycle—ensuring alignment as information evolves.
By working closely with Parexel, Weave developed NDA capabilities shaped by real-world submission experience. This collaboration brings together regulatory expertise and AI development to support accuracy, consistency, and scale in NDA authoring.
What this means for regulatory teams
NDA submissions represent one of the most complex and high-stakes phases in drug development. As a result, teams must manage large volumes of data while maintaining clarity, traceability, and alignment across contributors.
With NDA workflows now available, the Weave platform supports how teams structure, author, and verify content at scale. By connecting underlying data with document development, teams can reduce manual effort while maintaining control over narrative and quality.
In addition, the platform reflects how regulatory work happens in practice—supporting collaboration across functions and adapting as programs evolve. As teams move from early development through submission, maintaining continuity across data, context, and content becomes increasingly important.
Looking ahead
Looking ahead, Weave will continue expanding platform coverage across the regulatory lifecycle, building on the foundation established with NDA workflows. As regulatory demands increase, supporting teams through high-stakes milestones with connected systems will remain a priority.
At the same time, Weave will continue developing AI capabilities grounded in how regulatory teams actually work—ensuring that data, decisions, and content remain aligned as programs evolve. Partnerships like the one with Parexel will play a key role in shaping how the platform grows, with input rooted in real-world submission experience.